High prevalence of fecal carriage of extended-spectrum beta-lactamase producing Enterobacterales among patients with urinary tract infections in rural Tanzania

被引:0
|
作者
Macha, Magreth Erick [1 ,2 ,3 ]
Qi, Weihong [4 ]
Seiffert, Salome N. [5 ]
Bosch, Anja [2 ]
Kohler, Philipp [6 ]
Urassa, Honorathy Msami [7 ]
Haller, Sabine [6 ]
West, Erin [8 ]
Rohacek, Maja Weisser [9 ,10 ,11 ]
Babouee Flury, Baharak [2 ,6 ,8 ,12 ]
机构
[1] St Francis Univ, Coll Hlth & Allied Sci, Ifakara, Tanzania
[2] Kantonsspital St Gallen, Med Res Ctr, St Gallen, Switzerland
[3] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland
[4] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland
[5] Ctr Lab Med, Div Human Microbiol, St Gallen, Switzerland
[6] Kantonsspital St Gallen, Div Infect Dis Infect Prevent & Travel Med, St Gallen, Switzerland
[7] St Francis Reg Referral Hosp, Ifakara, Tanzania
[8] Kantonsspital St Gallen, Clin Trials Unit, St Gallen, Switzerland
[9] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland
[10] Swiss Trop & Publ Hlth Inst, Allschwil, Switzerland
[11] Ifakara Hlth Inst, Ifakara, Tanzania
[12] Univ Bern, Bern Univ Hosp, Inselspital, Dept Infect Dis, Bern, Switzerland
关键词
fecal carriage; extended-spectrum beta-lactamase; enterobacterales; urinary tract infections; rural Tanzania; ESBL-PRODUCING ENTEROBACTERIACEAE; COMMUNITY; HIV;
D O I
10.3389/fmicb.2024.1517182
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction The global rise of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) challenges resource-limited countries with insufficient laboratory infrastructure. This study investigates fecal carriage and risk factors for ESBL-PE and carbapenemase-producing organisms among patients with urinary tract infection (UTI) in rural Tanzania. Methods This cross-sectional study was conducted at St. Francis Regional Referral Hospital, Ifakara, Tanzania, from October 2021 to August 2023, involving 326 UTI patients. Demographic data and resistance risk factors were collected via structured questionnaires. Stool samples collected pre-antibiotic treatment were screened for ESBL-PE and carbapenemase locally. Positive samples underwent further analysis in Switzerland using MALDI-ToF, Vitek MS, and whole-genome sequencing. Multivariable analysis assessed predictors associated with ESBL-PE carriage for risk factors with p < 0.05. Results We enrolled 326 UTI patients (median age: 35.5 years, range: 25-52) and 189 (58.0%) were females. Fecal ESBL-PE colonization was detected in 70.9% of patients, predominantly E. coli (62.8%) and K. pneumoniae (33.0%). Whole-genome sequencing identified diverse phylogroups and sequence types, with CTX-M-15 being the most common ESBL gene. IncF plasmids were the primary carriers. Younger age (aOR: 0.98, 95% CI: 0.97-0.99; p = 0.0239) and inpatient status (aOR: 1.77, 95% CI: 1.08-2.91; p = 0.0036) were significant risk factors for ESBL-PE carriage. Conclusion The high prevalence of ESBL-PE fecal carriage in rural Tanzania highlights the need for improved infection control and further research into community transmission dynamics.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Fecal Carriage and Epidemiology of Extended-Spectrum Beta-Lactamase/Carbapenemases Producing Enterobacterales Isolates in Bulgarian Hospitals
    Markovska, Rumyana
    Stankova, Petya
    Stoeva, Temenuga
    Ivanova, Dobrinka
    Pencheva, Daniela
    Kaneva, Radka
    Boyanova, Lyudmila
    ANTIBIOTICS-BASEL, 2021, 10 (06):
  • [2] Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales in healthy Spanish schoolchildren
    Lopez-Siles, Mireia
    Moure, Zaira
    Muadica, Aly Salimo
    Sanchez, Sergio
    Cruces, Raquel
    avila, Alicia
    Lara, Noelia
    Koster, Pamela Carolina
    Dashti, Alejandro
    Oteo-Iglesias, Jesus
    Carmena, David
    McConnell, Michael J.
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [3] Prevalence of Extended-Spectrum Beta-lactamase Producing Microorganisms and Respiratory Infections
    Hurtado E. J, Soto
    Fernandez M. J, Gutierrez
    Rodriguez J, Castro
    Rascon M, Zaragoza
    Gonzalez-Miret J M
    ALLERGY, ASTHMA, IMMUNOPHYSIOLOGY & NOREHABILITOLOGY: INNOVATIVE TECHNOLOGIES, 2017,
  • [4] Risk of relapse of urinary tract infections due to extended-spectrum beta-lactamase producing organisms
    Irwin, Adriane
    Patel, Sumit
    McGregor, Jessina C.
    Bearden, David T.
    Delate, Thomas
    PHARMACOTHERAPY, 2015, 35 (11): : E195 - E196
  • [5] Fecal Carriage of Extended-spectrum Beta-lactamase and AmpC Beta-lactamase-producing Enterobacteriaceae in a Turkish Community
    Hazirolan, G.
    Mumcuoglu, I.
    Altan, G.
    Ozmen, B. B.
    Aksu, N.
    Karahan, Z. C.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2018, 21 (01) : 81 - 86
  • [6] Detection of extended-spectrum beta-lactamase production in Enterobacteriales from patients with suspected urinary tract infections, Tabora region, Rural Tanzania
    Nestor, David
    Malmvall, Bo-Eric
    Masonda, Yohana Paul
    Msafiri, John
    Sundqvist, Martin
    APMIS, 2018, 126 (08) : 700 - 702
  • [7] In vitro Activity of Cefmetazole and Flomoxef among Extended-Spectrum Beta-Lactamase producing Enterobacterales
    Iio, Koji
    Hagiya, Hideharu
    Higashionna, Tsukasa
    Otsuka, Fumio
    NEW MICROBIOLOGICA, 2023, 46 (04): : 348 - 353
  • [8] Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria
    Alsubaie, Mohammed A.
    Alsuheili, Abdullah Z.
    Aljehani, Mohammed N.
    Alothman, Abdulrahman A.
    Alzahrani, Abdulaziz S.
    Mohammedfadel, Hamza A.
    Alnajjar, Abeer A.
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [9] Etiologic agents and extended-spectrum beta-lactamase production in urinary tract infections
    Ramazanzadeh, R.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 : 160 - 160
  • [10] EPIDEMIOLOGICAL FEATURES OF URINARY TRACT INFECTIONS CAUSED BY ENTEROBACTERIACEAE EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) PRODUCING
    Garcia-Tello, A.
    Soria, T.
    Rodriguez, N.
    Torres, G.
    Mateo, E.
    Cacho, J.
    Gonzalez, J.
    Nunez, C.
    Angulo, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 230 - 230